SCHEMBL13439273

SCHEMBL13439273

Cc1c(C(F)(F)F)cnc(NC[C@H]2CC[C@H](N)CC2)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCQ Q04759 4/20 0.46
▸ FLT3 P36888 7/20 0.39
▸ KIT P10721 3/20 0.39
▸ MERTK Q12866 4/20 0.39
▸ TYRO3 Q06418 3/20 0.39
▸ GAS6 Q14393 2/20 0.39
▸ TLR7 Q9NYK1 1/20 0.37
▸ AXL P30530 2/20 0.37
▸ BTK Q06187 1/20 0.37
▸ CHEK1 O14757 2/20 0.37
▸ USP7 Q93009 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.34
▸ CCNB2 O95067 1/20 0.34
▸ CCNE2 O96020 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CDK4 P11802 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11935529 1.00 PRKCQ (0.46) PRKCQFLT3KITMERTKTYRO3
SCHEMBL13564911 0.78 PRKCQ (0.38) PRKCQFLT3
SCHEMBL11935458 0.76 LIPC (0.44) PRKCQTLR7
SCHEMBL13462615 0.76 LIPC (0.44) PRKCQTLR7
SCHEMBL13439187 0.76 LIPC (0.44) PRKCQTLR7
SCHEMBL27777337 0.70 ALDH1A1 (0.33) FLT3KITLRRK2
SCHEMBL1936270 0.70 PRKCQ (0.58) PRKCQFLT3TLR7CHEK1
SCHEMBL13439188 0.69 CNR2 (0.45) FLT3KIT
SCHEMBL11935457 0.69 CNR2 (0.45) FLT3KIT
SCHEMBL11935848 0.69 CHEK1 (0.45) FLT3KITCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150507-B2 Amine derivative having NPY Y5 receptor antagonistic activity SHIONOGI & CO., LTD. (JP) 2015-10-06 — — US disclosed
US-9150507-B2 Amine derivative having NPY Y5 receptor antagonistic activity SHIONOGI & CO., LTD. (JP) 2015-10-06 — — US disclosed
US-20100063027-A1 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity SHIONOGI & CO., LTD. (JP) 2010-03-11 — — US disclosed
US-20100063027-A1 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity SHIONOGI & CO., LTD. (JP) 2010-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063027-A1 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity NPY5R, NPY1R, NPY2R PRKCQ 3402/4885FLT3 731/4885KIT 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback